KANABO GROUP PLC Logo

KANABO GROUP PLC

A digital health firm focused on cannabis products and telehealth services.

KNB | IL

Overview

Corporate Details

ISIN(s):
GB00BYQCS703
LEI:
213800XPJFSNWJIYKN52
Country:
United Kingdom
Address:
Churchill House, NW4 4DJ London

Description

Kanabo Group PLC is a digital health company focused on the research, development, and commercialization of cannabis-derived products. The company distributes cannabis-derived formulations for medical patients and non-THC products for CBD consumers. Its research and development efforts create proprietary, patent-pending formulas for conditions such as sleep and central nervous system (CNS) disorders. A key component of its offering is the VapePod®, a medically certified vaporization device that enables precise, metered-dosing of cannabis extracts. The company also operates The GP Service, a telehealth platform providing digital health services, including video consultations and online prescriptions, which integrates primary care with its specialist medicine offerings.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-11 12:45
Disposal of Subsidiary: The GP Service Limited
English 7.8 KB
2025-11-28 17:15
Appointment of Joint Administrators
English 10.8 KB
2025-03-04 08:00
Revenue Growth, Trading and Operational Update
English 19.6 KB
2025-01-06 08:00
Directorate Change
English 11.3 KB
2024-11-19 10:55
The GP Service Wins Award
English 9.2 KB
2024-10-31 10:48
Correction Director/PDMR Shareholding
English 27.2 KB
2024-10-29 12:39
Director/PDMR Shareholding
English 26.7 KB
2024-09-30 15:50
Half-year Report
English 307.5 KB
2024-08-28 15:31
Director/PDMR Shareholding
English 35.2 KB
2024-06-27 17:49
Result of AGM
English 23.0 KB
2024-06-04 08:00
Expansion:14 New Clinics Partnership with Treat-It
English 16.6 KB
2024-05-31 11:30
Notice of AGM
English 12.0 KB
2024-04-30 15:15
Annual Financial Report
English 895.4 KB
2024-03-28 08:00
Expansion of Treat It to Mental Health Treatments
English 14.0 KB
2024-03-27 18:11
Holding(s) in Company
English 24.2 KB

Automate Your Workflow. Get a real-time feed of all KANABO GROUP PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for KANABO GROUP PLC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for KANABO GROUP PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Annexon, Inc. Logo
Clinical-stage biopharma developing complement medicines by inhibiting C1q.
United States of America
ANNX
ANTEROGEN CO., LTD. Logo
Develops and commercializes cell therapies and orphan drugs using adult stem cells.
South Korea
065660
Antibiotice S.A. Logo
Pharmaceutical firm manufacturing generic medicines, anti-infectives, and APIs.
Romania
ATB
Apellis Pharmaceuticals, Inc. Logo
Biopharmaceutical company developing therapies by targeting the complement cascade.
United States of America
APLS
Apimeds Pharmaceuticals US, Inc. Logo
Clinical-stage biopharma developing a bee venom drug and AI digital treasury solutions.
United States of America
APUS
Apogee Therapeutics, Inc. Logo
Clinical-stage biotech developing biologics for immunological and inflammatory diseases.
United States of America
APGE
Apollomics Inc. Logo
Clinical-stage biotech developing innovative oncology and combination therapies.
United States of America
APLM
Apontis Pharma AG Logo
Develops and markets fixed-dose combination drugs (Single Pills) for chronic diseases.
Germany
APPH
Applied Therapeutics, Inc. Logo
Clinical-stage biopharma developing novel drugs for rare metabolic and CNS diseases.
United States of America
APLT
Aprogen Biologics Inc. Logo
Develops and manufactures novel biologics and biosimilar antibody-based therapeutics.
South Korea
003060

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.